Clinical trial
A Multicenter Phase II Trial of Weekly Gemcitabine, Paclitaxel, and Hyperfractionated External Irradiation (63.80 GY) for Locally Advanced Pancreatic Cancer
NCT00226746 is registered in ClinicalTrials.gov with New York Presbyterian Brooklyn Methodist Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter Phase II Trial of Weekly Gemcitabine, Paclitaxel, and Hyperfractionated External Irradiation (63.80 GY) for Locally Advanced Pancreatic Cancer
- Lead sponsor
- New York Presbyterian Brooklyn Methodist Hospital
- Phase
- Phase 2
- Overall status
- Withdrawn
- Start date
- March 31, 2003
- Completion date
- June 30, 2012
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.